How-Specialty-Pharmacists-Can-Keep-HIV-Patients-on-ART

Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzA team of specialty pharmacists and pharmacy liaisons in Brooklyn successfully transitioned a small group of patients living with HIV from daily oral antiviral therapy (ART) to injectable long-acting antiretroviral therapy (LA-ART). The switch improved medication access and adherence, and optimized treatment outcomes for HIV management and PrEP, the team reported at the NASP 2025 Annual Meeting & Expo, in